1. Trang chủ
  2. » Luận Văn - Báo Cáo

Nghiên ứu xây dựng quy trình hẩn đoán đột biến gene kras

76 0 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 76
Dung lượng 3,46 MB

Nội dung

Yoshino, T., et al., TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.. Colorectal cancer in inflammatory bowe

  - T  GENE KRAS  (CÔNG NGH SINH H ) : TS  PGS TS T - 2013 17081779625878cca1030-7650-47a1-b6c6-99e1262206df 170817796258757f0e688-4f99-4b93-b6c3-6510a833c081 1708177962587f75ffb85-d193-474f-a89d-de6a8a381bca         10  11  14  14  14  14  15  17  17  18  .19  23  34 1.5 KRAS   37  2011 - 2013              GENE KRAS 40  .40  42  43  43  .43 2.1.2 Hóa ch 43  .44 2.2 45  45  .46  46  .48 2.2.5              -Dual Priming-Oligonucleotide) 49  52  56  56 6 56  2011 - 2013               KRAS 57  59  60  61  KRAS 62              64  67  68  69  2011 - 2013     Trung, khoa S t n  l Tôi  sinh-Vi -        -       Tôi                 B                                   -                      tháng 09     2011 - 2013        do v   2011 - 2013   DAN APC: adenomatous polyposis coli EMEA:European Medicines Agenecy AKT: v-akt murine thymoma viral ESMO: European society for medical oncogene homolog oncology anti-EGFR mABs: anti-EGFR monoclonal ERBB: v-erb-b1 avian erythroblastic antibodies leukemia viral oncogene homolog BRAF: v-Raf murine sarcoma viral EDTA: Ethylene diamine tetraacetic acid oncogene CD: Crohn's disease CIN: Chromosomal instability CpG: Cytosine-phosphate-guanine CIMP: CpG Island Methylator Phenotype  ERK: extracellular-signal regulated kinase FDA: Food and drug administration FAP: Familial Adenomatous Polyp FRZ: Frizzled GSK-e-3 GRB: growth factor receptor-bound CDK: cyclin dependent kinases protein DPO: Dual priming oligo GEFs: Guanine nucleotide exchange DCC: deleted in colorectal carcinoma DNA: Deoxyribonucleic acid DNMT: DNA methyltransferase DTCS: Dye terminating cycle sequencing ddNTP: dideoxynucleotide triphosphate factors GAPs: GTPase-activating proteins GTP: Guanosine-5'-triphosphate GDP: Guanosine diphosphate HNPCC: Hereditary non-polyposis colorectal cancer EGFR: Epidermal growth factor receptor  2011 - 2013   HER: human epidermal growth factor HLH1: hemophagocytic receptor lymphohistiocytosis HAT: Histon acetyltransferase mt: mutant HDAC: Histon deacetylase NST HRM: High Resolution Melting IBD: Inflammatory bowel disease IGF1R: insulin-like growth-factor-1 OD: Optical density p53: protein p53 p21: protein p21 receptors PI3K: Phosphoinositide 3-kinase IRS-1: insulin receptor substrate PDGFR: platelet-derived growth-factor JUN: jun proto-oncogene KRAS: V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog LRP: lipoprotein receptor-related protein MEK: mitogene-activated protein kinase MAPK: mitogene activated protein kinase MMR: Mismatch repair enzymes MSH: mutS homolog receptor PIP2: phosphatidylinositol-4, 5bisphosphate PIP3: phosphatidylinositol-3,4,5trisphosphate PDK: phosphoinositide-dependent kinase PTEN: Phosphatase and tensin homologue PIK3CA: Phosphatidylinositol-4,5- MeCP2: methyl CpG binding protein bisphosphate 3-kinase MBD: methyl-CpG binding domain PBS: Phosphate buffer saline protein MLH1: mutL homolog  PCR: Polymerase chain reaction pH: Hydrogene power 2011 - 2013   MSI: Microsatellite instability SFRPs: Secreted Frizzled-related proteins SOS: son of sevenless TGFBR: transforming growth factor beta receptor SHC: Src homology TP53: tumor protein p53 SDS: Sodium dodecyl sulfate UICC: Union for International Cancer TE: Tris-EDTA Control TGF-transforming growth factor beta TGFB:transforming growth factor beta  mTOR: mammalian target of rapamycin RNA: Ribonucleic acid UC: Ulerative colitis WNT: Wingless-type wt: Wild type RTK: receptor tyrosine kinase  bp Base pair mm minimetter Centigrade mM Millimolar Ct Threshold cycle mg Milligram h Hour nm Nanometer kDa KiloDaltons rpm Revolutions per mimute M Molar µg Microgram mL Milliliter  Microliter C  2011 - 2013     39 KRAS 41 Realtime  .51 KRAS máy Realtime PCR 52  53 (Stop Solution) .54 2 56  56  KRAS  63 Realtime  .64 AS máy Realtime  65  10 2011 - 2013

Ngày đăng: 18/02/2024, 12:35

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

w